1. Home
  2. NUWE vs MSPR Comparison

NUWE vs MSPR Comparison

Compare NUWE & MSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUWE
  • MSPR
  • Stock Information
  • Founded
  • NUWE 1999
  • MSPR 2014
  • Country
  • NUWE United States
  • MSPR United States
  • Employees
  • NUWE N/A
  • MSPR N/A
  • Industry
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MSPR
  • Sector
  • NUWE Health Care
  • MSPR
  • Exchange
  • NUWE Nasdaq
  • MSPR NYSE
  • Market Cap
  • NUWE 3.9M
  • MSPR N/A
  • IPO Year
  • NUWE N/A
  • MSPR N/A
  • Fundamental
  • Price
  • NUWE $0.96
  • MSPR $1.96
  • Analyst Decision
  • NUWE Strong Buy
  • MSPR
  • Analyst Count
  • NUWE 1
  • MSPR 0
  • Target Price
  • NUWE $17.00
  • MSPR N/A
  • AVG Volume (30 Days)
  • NUWE 55.0K
  • MSPR 4.6M
  • Earning Date
  • NUWE 05-13-2025
  • MSPR 05-19-2025
  • Dividend Yield
  • NUWE N/A
  • MSPR N/A
  • EPS Growth
  • NUWE N/A
  • MSPR N/A
  • EPS
  • NUWE N/A
  • MSPR N/A
  • Revenue
  • NUWE $8,740,000.00
  • MSPR $18,249,000.00
  • Revenue This Year
  • NUWE $22.96
  • MSPR N/A
  • Revenue Next Year
  • NUWE $29.97
  • MSPR N/A
  • P/E Ratio
  • NUWE N/A
  • MSPR N/A
  • Revenue Growth
  • NUWE N/A
  • MSPR 574.64
  • 52 Week Low
  • NUWE $0.75
  • MSPR $1.10
  • 52 Week High
  • NUWE $11.55
  • MSPR $22.25
  • Technical
  • Relative Strength Index (RSI)
  • NUWE 50.79
  • MSPR N/A
  • Support Level
  • NUWE $0.89
  • MSPR N/A
  • Resistance Level
  • NUWE $1.00
  • MSPR N/A
  • Average True Range (ATR)
  • NUWE 0.08
  • MSPR 0.00
  • MACD
  • NUWE 0.01
  • MSPR 0.00
  • Stochastic Oscillator
  • NUWE 55.73
  • MSPR 0.00

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Share on Social Networks: